Latest News

FDA approves Kebilidi as first gene therapy to treat aromatic L-amino acid decarboxylase deficiency | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves Kebilidi as first gene therapy to treat aromatic L-amino acid decarboxylase deficiency

November 14th 2024

With the decision, Kebilidi becomes the first FDA-approved gene therapy for AADC deficiency, and is indicated for adult and pediatric patients.

ADHD treatment: Clinical pearls for primary care providers
ADHD treatment: Clinical pearls for primary care providers

November 14th 2024

FDA accepts BLA resubmission for pz-cel to treat recessive dystrophic epidermolysis bullosa | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts BLA resubmission for pz-cel to treat recessive dystrophic epidermolysis bullosa

November 13th 2024

Early intratracheal budesonide has little to no effect on survival free of bronchopulmonary dysplasia | Image Credit: © Rasi - © Rasi - stock.adobe.com.
Early intratracheal budesonide has little to no effect on survival free of bronchopulmonary dysplasia

November 13th 2024

AAP, AHA updates guidance for resuscitation following drowning | Image Credit: © Aleksandra Konoplya - © Aleksandra Konoplya - stock.adobe.com.
AAP, AHA update guidance for resuscitation following drowning

November 12th 2024

Latest Videos
Podcasts

All News

© 2024 MJH Life Sciences

All rights reserved.